Literature DB >> 25117880

Renal denervation as a friend of catheter ablation in patients with atrial fibrillation and hypertension.

Meng Zhang1, Hui Tao, Kai-Hu Shi.   

Abstract

Entities:  

Year:  2014        PMID： 25117880     DOI： 10.1007/s00392-014-0752-9

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN： 1861-0684            Impact factor:   5.460


× No keyword cloud information.
  6 in total

Review 1.  Renal denervation: effects on atrial electrophysiology and arrhythmias.

Authors:  Dominik Linz; Arne van Hunnik; Christian Ukena; Sebastian Ewen; Felix Mahfoud; Stephan H Schirmer; Matthias Lenski; Hans-Ruprecht Neuberger; Ulrich Schotten; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2014-03-29       Impact factor: 5.460

2.  Comparing the imperfect with the imperfect: the imprecise science of assessing the risk and benefits of anticoagulation in atrial fibrillation.

Authors:  Alex Y Tan; Kenneth A Ellenbogen
Journal:  Circulation       Date:  2014-03-29       Impact factor: 29.690

3.  Adjunctive renal sympathetic denervation to modify hypertension as upstream therapy in the treatment of atrial fibrillation (H-FIB) study: clinical background and study design.

Authors:  Humera Ahmed; Marc A Miller; Srinivas R Dukkipati; Sam Cammack; Jacob S Koruth; Sandeep Gangireddy; Betsy A Ellsworth; Andre D'Avila; Michael Domanski; Annetine C Gelijns; Alan Moskowitz; Vivek Y Reddy
Journal:  J Cardiovasc Electrophysiol       Date:  2013-02-19

4.  Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension: early experience.

Authors:  Evgeny Pokushalov; Alexander Romanov; Demosthenes G Katritsis; Sergey Artyomenko; Sevda Bayramova; Denis Losik; Vera Baranova; Alexander Karaskov; Jonathan S Steinberg
Journal:  Heart Rhythm       Date:  2014-03-29       Impact factor: 6.343

5.  A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension.

Authors:  Evgeny Pokushalov; Alexander Romanov; Giorgio Corbucci; Sergey Artyomenko; Vera Baranova; Alex Turov; Natalya Shirokova; Alexander Karaskov; Suneet Mittal; Jonathan S Steinberg
Journal:  J Am Coll Cardiol       Date:  2012-09-05       Impact factor: 24.094

6.  International expert consensus statement: Percutaneous transluminal renal denervation for the treatment of resistant hypertension.

Authors:  Markus P Schlaich; Roland E Schmieder; George Bakris; Peter J Blankestijn; Michael Böhm; Vito M Campese; Darrel P Francis; Guido Grassi; Dagmara Hering; Richard Katholi; Sverre Kjeldsen; Henry Krum; Felix Mahfoud; Giuseppe Mancia; Franz H Messerli; Krzysztof Narkiewicz; Gianfranco Parati; Krishna J Rocha-Singh; Luis M Ruilope; Lars C Rump; Domenic A Sica; Paul A Sobotka; Costas Tsioufis; Oliver Vonend; Michael A Weber; Bryan Williams; Thomas Zeller; Murray D Esler
Journal:  J Am Coll Cardiol       Date:  2013-09-18       Impact factor: 24.094
  6 in total
  9 in total

1.  Successful single-sided renal denervation in drug-resistant hypertension and ventricular tachycardia.

Authors:  Sebastian Hilbert; Cathleen Rogge; Polykarpos Papageorgiou; Gerhard Hindricks; Andreas Bollmann
Journal:  Clin Res Cardiol       Date:  2014-11-11       Impact factor: 5.460

2.  Visualization and ablation of the autonomic nervous system corresponding to ganglionated plexi guided by D-SPECT 123I-mIBG imaging in patient with paroxysmal atrial fibrillation.

Authors:  Alexander Romanov; Stanislav Minin; Christopher Breault; Evgeny Pokushalov
Journal:  Clin Res Cardiol       Date:  2016-10-17       Impact factor: 5.460

3.  Renal denervation for treatment of hypertension and beyond.

Authors:  Dominik Linz; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2014-08-20       Impact factor: 5.460

4.  Catheter ablation of paroxysmal atrial fibrillation: circumferential pulmonary vein ablation: success rates with and without exclusion of areas adjacent to the esophagus.

Authors:  Klaus Kettering; Dag-Hau Yim; Alexander Benz; Felix Gramley
Journal:  Clin Res Cardiol       Date:  2017-05-10       Impact factor: 5.460

Review 5.  Atrial fibrillation and long-term sports practice: epidemiology and mechanisms.

Authors:  S Wernhart; M Halle
Journal:  Clin Res Cardiol       Date:  2014-12-25       Impact factor: 5.460

Review 6.  Renal sympathetic denervation for treatment of ventricular arrhythmias: a review on current experimental and clinical findings.

Authors:  Bing Huang; Benjamin J Scherlag; Lilei Yu; Zhibing Lu; Bo He; Hong Jiang
Journal:  Clin Res Cardiol       Date:  2015-01-18       Impact factor: 5.460

7.  Elevated M2-muscarinic and β1-adrenergic receptor autoantibody levels are associated with paroxysmal atrial fibrillation.

Authors:  Muhammed U Yalcin; Kadri M Gurses; Duygu Kocyigit; Sacit Altug Kesikli; Ahmet Hakan Ates; Banu Evranos; Hikmet Yorgun; Mehmet L Sahiner; Ergun B Kaya; Mehmet A Oto; Dicle Guc; Necla Ozer; Kudret Aytemir
Journal:  Clin Res Cardiol       Date:  2014-10-29       Impact factor: 5.460

8.  Renal artery sympathetic denervation: observations from the UK experience.

Authors:  Andrew S P Sharp; Justin E Davies; Melvin D Lobo; Clare L Bent; Patrick B Mark; Amy E Burchell; Simon D Thackray; Una Martin; William S McKane; Robert T Gerber; James R Wilkinson; Tarek F Antonios; Timothy W Doulton; Tiffany Patterson; Piers C Clifford; Alistair Lindsay; Graeme J Houston; Jonathan Freedman; Neelan Das; Anna M Belli; Mohamad Faris; Trevor J Cleveland; Angus K Nightingale; Awais Hameed; Kalaivani Mahadevan; Judith A Finegold; Adam N Mather; Terry Levy; Richard D'Souza; Peter Riley; Jonathan G Moss; Carlo Di Mario; Simon R Redwood; Andreas Baumbach; Mark J Caulfield; Indranil Dasgupta
Journal:  Clin Res Cardiol       Date:  2016-01-22       Impact factor: 5.460

9.  Role and mechanism of lncRNA under magnetic nanoparticles in atrial autonomic nerve remodeling during radiofrequency ablation of recurrent atrial fibrillation.

Authors:  Weifeng Jiang; Ming Xu; Mu Qin; Daoliang Zhang; Shaohui Wu; Xu Liu; Yu Zhang
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.